Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC

Acta Haematol. 2023;146(2):161-165. doi: 10.1159/000528242. Epub 2022 Nov 29.

Abstract

Acute diarrhea is a common and debilitating complication in recipients of allogeneic hematopoietic stem cell transplantation (HCT). In this prospective, observational, and multicenter study we examined all episodes occurring in the first 6 months of 142 consecutive adult patients who underwent a reduced-intensity conditioning HCT in 10 Spanish tertiary university hospitals. Fifty-four patients (38%) developed a total of 75 acute diarrhea episodes. The median time from HCT to the first episode was 38 days (4-157). The main cause of enterocolitis was lower GI-aGVHD (38%), followed by infections (21%) and drug-related toxicity (8%). Causative infectious causes were identified in only 16/75 episodes (21%). C. difficile-related infection was the most common infectious agent with an incidence and recurrence of 13% and 2%, respectively. With a median follow-up for survivors of 32 months, the non-relapse mortality (NRM) and the overall survival (OS) at 1 year, were 20% (95% C.I.: 14-28%) and 69% (95% C.I.: 61-77%), respectively. Development of enterocolitis was not associated with higher NRM (p = 0.37) or worse OS (p = 0.9). This real-life study confirms that the diagnosis and management of acute diarrhea in the early stages after HCT is challenging. Nosocomial infections seem to be relatively uncommon, probably due to more rational use of antibiotics.

Keywords: Allogenic stem transplant; Infectious enterocolitis; Reduced-intensity conditioning.

Publication types

  • Observational Study
  • Multicenter Study
  • News

MeSH terms

  • Acute Disease
  • Adult
  • Chronic Disease
  • Clostridioides difficile*
  • Diarrhea* / etiology
  • Diarrhea* / mortality
  • Enterocolitis / chemically induced
  • Enterocolitis / etiology
  • Enterocolitis / mortality
  • Graft vs Host Disease* / etiology
  • Graft vs Host Disease* / mortality
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hematopoietic Stem Cell Transplantation* / methods
  • Hematopoietic Stem Cell Transplantation* / mortality
  • Humans
  • Prospective Studies
  • Transplantation Conditioning / adverse effects
  • Transplantation, Homologous / adverse effects